Pharmacologic Class Information
|Insulin-like Growth Factor-1 Receptor Inhibitors
|Mechanisms of Action - [MoA]
|Pharmacologic Concept Description
|This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.
NDC Products with Insulin-like Growth Factor-1 Receptor Inhibitors
The table contains 1 products whose active ingredient are classified under the same pharmacologic class Insulin-like Growth Factor-1 Receptor Inhibitors [MoA].
|Non-Proprietary Name: Teprotumumab
|Injection, Powder, Lyophilized, For Solution
|Horizon Therapeutics Usa, Inc.